Showing results (391-400 of 610) with videos related to

Sort By:
Pageof 61
Blood|March 1, 1991
Requirement of heparin for arterial and venous thrombolysis with recombinant tissue-type plasminogen activatorH J Rapold, H R Lu, Z M Wu, et al.
Circulation|November 1, 1986
Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarctionF Van de Werf, J Vanhaecke, H de Geest, et al.
Human Molecular Genetics|September 16, 1998
Characterization of a double homeodomain protein (DUX1) encoded by a cDNA homologous to 3.3 kb dispersed repeated elementsH Ding, M C Beckers, S Plaisance, et al.
Circulation|April 18, 2001
Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in miceM Levi, L Moons, A Bouché, et al.
Molecular Reproduction and Development|December 1, 1996
Pluripotential rabbit embryonic stem (ES) cells are capable of forming overt coat color chimeras following injection into blastocystsL Schoonjans, G M Albright, J L Li, et al.
Thrombosis Research|March 1, 1984
Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditionsI Juhan-Vague, B Moerman, F De Cock, et al.
Thrombosis Research|October 15, 1985
Aspirin, indomethacin and dazoxiben do not affect the fibrinolytic activation induced by venous occlusionH Bounameaux, P Gresele, M Hanss, et al.
European Journal of Biochemistry|August 15, 1988
Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1)M C Alessi, P J Declerck, M De Mol, et al.
Acta Clinica Belgica|January 1, 1992
A randomized placebo controlled trial on the effects of simvastatin, a HMG-CoA reductase inhibitor, on blood lipids and fibrinolytic parametersH Jacobs, F Van de Werf, E Lesaffre, et al.
European Heart Journal|August 1, 1987
Treatment of prosthetic tricuspid valve thrombosis with recombinant tissue-type plasminogen activatorP Cambier, P Mombaerts, H De Geest, et al.
Pageof 61